11 – 20 of 132
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Emergency subtotal colectomy rates in relation to anti-TNF therapy in inflammatory bowel disease patients : comparison of retrospective cohorts
Sajjadi, Saman LU ; Svensson Neufert, Rebecca LU
; Ruhr, Emilia
; Tryggmo, Sebastian
; Marsal, Jan
LU
and Buchwald, Pamela
LU
(2023)
In Scandinavian Journal of Gastroenterology
58(1).
p.15-19
- Contribution to journal › Article
- 2022
-
Mark
Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis
Sagard, Jonas LU
; Olofsson, Tor
LU
; Mogard, Elisabeth
LU
; Marsal, Jan
LU
; Andréasson, Kristofer
LU
; Geijer, Mats
LU
; Kristensen, Lars Erik
LU
; Lindqvist, Elisabet
LU
and Wallman, Johan K
LU
(2022)
In Arthritis Research & Therapy
24.
p.1-14
- Contribution to journal › Article
-
Mark
A novel food-based negative oral contrast agent compared with two conventional oral contrast agents in abdominal CT : a three-arm parallel blinded randomised controlled single-centre trial
Leander, Peter LU ; Stathis, Georgios ; Casal-Dujat, Lucia LU ; Boman, Karolina ; Adnerhill, Ingvar LU ; Marsal, Jan LU
; Böök, Olof
and Fork, Thomas
LU
(2022)
In European Radiology Experimental
6(1).
- Contribution to journal › Article
-
Mark
Editorial: intravenous to subcutaneous vedolizumab—switch without glitch! Authors' reply
Bergqvist, Viktoria LU ; Holmgren, Johanna LU ; Klintman, Daniel LU and Marsal, Jan LU
(2022)
In Alimentary Pharmacology and Therapeutics
- Contribution to journal › Debate/Note/Editorial
-
Mark
Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes : A nationwide study
Mårild, Karl ; Söderling, Jonas ; Stephansson, Olof ; Axelrad, Jordan ; Halfvarson, Jonas ; Bröms, Gabriella ; Marsal, Jan LU
; Olén, Ola
and Ludvigsson, Jonas F.
(2022)
In EClinicalMedicine
53.
- Contribution to journal › Article
-
Mark
Leverns Funktioner. : Ett metabolt, biologiskt och kliniskt perspektiv
(2022)
- Book/Report › Book
-
Mark
Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease
Bergqvist, Viktoria LU ; Holmgren, Johanna LU ; Klintman, Daniel LU and Marsal, Jan LU
(2022)
In Alimentary pharmacology & therapeutics
55(11).
p.1389-1401
- Contribution to journal › Article
-
Mark
Letter: to switch or not to switch, that is the question—author's reply
Bergqvist, Viktoria LU ; Holmgren, Johanna LU ; Klintman, Daniel LU and Marsal, Jan LU
(2022)
In Alimentary Pharmacology and Therapeutics
56(5).
p.922-923
- Contribution to journal › Letter
-
Mark
Response to : Response to: Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: Is it an overlooked comorbidity?' by Proft et al.
Wallman, Johan Karlsson LU ; Mogard, Elisabeth LU
; Marsal, Jan
LU
; Andréasson, Kristofer
LU
; Jöud, Anna
LU
; Geijer, Mats
LU
; Kristensen, Lars Erik
LU
; Lindqvist, Elisabet
LU
and Olofsson, Tor
LU
(2022)
In Annals of the Rheumatic Diseases
81(1).
p.10-10
- Contribution to journal › Debate/Note/Editorial
- 2021
-
Mark
Lung Mast Cells Have a High Constitutive Expression of Carboxypeptidase A3 mRNA That Is Independent from Granule-Stored CPA3
Siddhuraj, Premkumar LU ; Clausson, Carl Magnus LU ; Sanden, Caroline LU ; Alyamani, Manar LU ; Kadivar, Mohammad LU ; Marsal, Jan LU
; Wallengren, Joanna
LU
; Bjermer, Leif
LU
and Erjefält, Jonas S.
LU
(2021)
In Cells
10(2).
- Contribution to journal › Article